16:33 IST
BSE
Management Change
Dr. Reddy's Laboratories Management Change
Dr. Reddy's Laboratories announced the resignation of Deepak Sapra, CEO of API and Services, effective November 12, 2026.
Dr. Reddy's Laboratories Ltd
Dr. Reddy's Laboratories Ltd news stories on ALFA NewsRead the news →- Share price
- ₹1,198.10
- Market cap
- ₹1,00,003 Cr
- Revenue (annual)
- ₹33,700 Cr
- Net profit (annual)
- ₹4,196 Cr
- P/E (TTM)
- 31.0×Sector 47.4×
- Promoter holding
- 26.64%+0.01% QoQ
- FII holding
- 20.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Price Movement Clarification 6Employee Stock Options 6Other Announcement 4Financial Results 4Business Update 4Earnings Call 3Board Meeting Outcome 3Product Launch 2Management Change 2Annual Report 2Annual General Meeting 2Regulatory Approval 1Partnership 1Merger & Restructuring 1Legal & Regulatory 1Capital Structure Change 1Board Meeting Date 1Adverse Business Impact 1
Time
2 announcements with these filters
16:21 IST
NSE
Management Change
Dr. Reddy's Laboratories Management Change
Dr. Reddy's Laboratories appointed Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, and appointed Deloitte Haskins & Sells, LLP for US reporting.